Creative Planning Regulus Therapeutics Inc. Transaction History

Creative Planning

  • $129 Billion
  • Q3 2025

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025
BUY
$0.97 - $1.75 $182 - $329
188 Added 1.33%
14,304 $25,000
Q4 2024

Feb 14, 2025
SELL
$1.4 - $1.71 $3,290 - $4,018
-2,350 Reduced 14.27%
14,116 $22,000
Q3 2024

Oct 11, 2024
BUY
$1.46 - $1.9 $24,040 - $31,285
16,466 New
16,466 $25,000

Others Institutions Holding RGLS

# of Institutions
4
Shares Held
4.52M
Call Options Held
0
Put Options Held
0
View Full List

About Regulus Therapeutics Inc.

RGLS Quotes by TradingView
  • Ticker RGLS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 14,634,400
  • Market Cap $119M
  • Description
  • Regulus Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the discovery and development of drugs that targets microRNAs to treat a range of diseases in the United States. Its product candidates include RG-012, an anti-miR targeting miR-21 that is in Phase II clinical trial for the treatment of Alport syndrome, a life-thre...
More about RGLS
Track This Portfolio

Track Creative Planning Portfolio

Follow Creative Planning and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

News

Stay updated on Creative Planning with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email